Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2527440 | Clinical Therapeutics | 2012 | 8 Pages |
Abstract
A favorable clinical cure rate was achieved with oral linezolid therapy when compared with intravenous vancomycin therapy in propensity score-matched patients with cSSTI proved to be caused by MRSA. ClinicalTrials.gov Identifier: NCT00087490.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Kamal M.F. MD, Pinaki PhD, Arlene MPH, Helen PhD, Alice M. MD, PhD,